Switch to:
Genomic Health Inc (NAS:GHDX)
EV/EBITDA
-61.10 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Genomic Health Inc's enterprise value is $879.8 Mil. Genomic Health Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Jun. 2016 was $-14.4 Mil. Therefore, Genomic Health Inc's EV/EBITDA ratio for today is -61.10.

During the past 13 years, the highest EV/EBITDA Ratio of Genomic Health Inc was 939.60. The lowest was -251.20. And the median was -15.95.

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Genomic Health Inc's stock price is $29.19. Genomic Health Inc's earnings per share for the trailing twelve months (TTM) ended in Jun. 2016 was $-0.81. Therefore, Genomic Health Inc's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Genomic Health Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=879.824/-14.399
=-61.10

Genomic Health Inc's current Enterprise Value is $879.8 Mil.
Genomic Health Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Jun. 2016 was -3.764 (Sep. 2015 ) + -1.095 (Dec. 2015 ) + -6.628 (Mar. 2016 ) + -2.912 (Jun. 2016 ) = $-14.4 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Genomic Health Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=29.19/-0.81
=

Genomic Health Inc's share price for today is $29.19.
Genomic Health Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Jun. 2016 was -0.36 (Sep. 2015 ) + -0.08 (Dec. 2015 ) + -0.19 (Mar. 2016 ) + -0.18 (Jun. 2016 ) = $-0.81.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Genomic Health Inc Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
ev2ebitda -15.40-22.38-46.30-235.2748.4942.0851.54-145.40-54.69-39.31

Genomic Health Inc Quarterly Data

Mar14Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16Jun16
ev2ebitda -62.10-57.57-40.93-54.69-35.23-25.64-19.57-39.31-35.39-53.49
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK